Media Centre
Latest press releases
-
US court decision favours Symbicort in patent litigation
-
AstraZeneca advances mass global rollout of COVID-19 vaccine through COVAX
-
Further update on US regulatory review of roxadustat in anaemia of chronic kidney disease
-
Tezepelumab is the first biologic to consistently and significantly reduce exacerbations in broad population of severe asthma patients
-
Voluntary withdrawal of Imfinzi indication in advanced bladder cancer in the US
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Email the Global Media Relations team at:
Gonzalo Viña
Head of Global Media Relations
+44 203 749 5916
Kim Blomley
Director Global Media Relations (Oncology)
+44 7385 367659
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 203 749 5906
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 122 334 4690
Jennifer Hursit
Manager Global Media Relations
+44 203 749 5762
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
